Former British Columbia Premier Christy Clark said Canopy Growth (NYSE:CGC,TSX:WEED) is the “best positioned of all the companies” in the highly regulated cannabis sector.

Constellation Brands (NYSE:STZ), one of Canopy Growth’s biggest partners, confirmed Clark’s appointment to its board of directors in September, alongside Jose Manuel Madero, citing Clark’s “extensive knowledge” of Canada’s regulatory and political environment as benefits.

Clark sat as the provincial premier from 2011 to 2017 after working as both the minister of education and minister of children and family development in British Columbia.


Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

In an interview with BNN Bloomberg on Friday (October 4), the former politician spoke about her excitement at joining the ranks at Constellation, a company she said is skilled at delivering on products in highly regulated industries.

Clark noted that the fledgling regulatory environment of the marijuana market won’t be well served by having a lot of smaller companies selling cannabis, but said Canopy Growth and Constellation have the capability to make the safe creation and distribution of cannabis products possible.

“There aren’t really any other companies in the cannabis space at the moment that have this level of capacity,” she said.

The former British Columbia premier isn’t the only player in the cannabis space with a political past. Former Canadian Prime Minister Brian Mulroney and former Speaker of the House John Boehner have both backed cannabis company Acreage Holdings (CSE:ACRG.U,OTCQX:ACRGF), another firm with a Canopy Growth deal.

Clark added that there is “huge potential on the (intellectual property) side” when it comes to the nascent industry, and said that further research on the medicinal applications of marijuana will be the biggest driver of growth. It is a space, she said, that Constellation will dominate.

The American beer maker pumped C$5 billion into Canopy last year to assist in branding, intellectual property and retailing for the cannabis company.

Clark’s addition to Constellation’s roster was another big management move for the company after former Canopy CEO Bruce Linton was pushed out of his role as chief executive.


Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

With the investment, a conditional board reconfigurement was set, and that same board, largely composed of Constellation executives, terminated Linton after being unimpressed by some less-than-stellar quarterly results.

Shares of Constellation took a hit last week after it released its results for Q2 2020 on Thursday (October 3). The company reported a loss of US$484.4 million from its stake in Canopy Growth.

Constellation also reported a US$757 million unrealized net gain in reported basis results since its initial C$245 million investment into Canopy in 2017. A US$839 million decrease in the fair value of its investment into Canopy was also recognized during the latest quarter for the alcohol maker.

Shares of Constellation dropped after the earnings report was released last week, falling 8.2 percent from a high of US$208.14 on Wednesday (October 2) to a low of US$191.02 on Thursday.

Constellation closed the trading day on Monday (October 7) at US$188.74.

Canopy Growth shares fared a bit better last week with a bit of fluctuation in New York from a high on Wednesday of US$22.58 to a low of US$21.52 on Thursday, a 4.7 percent decrease in value. Canopy was at US$22.23 at market close on Monday.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Danielle Edwards, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: Acreage Holdings is a client of the Investing News Network. This article is not paid-for content.


Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

First Units on Sale Today at Newburgh Dispensary with Availability Tomorrow at Carle Place , Forest Hills , and Plattsburgh Locations

With Enough Product to Supply Wholesale Partners by Month’s End

Keep reading... Show less

Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today that it has scheduled a conference call to discuss the results for its first quarter fiscal year 2022 on Tuesday, November 9, 2021 at 5:00 p.m. Eastern Time | 3:00 p.m. Mountain Time . The Company will report its financial results for the first quarter fiscal year 2022 after the close of markets that same day.

Keep reading... Show less

Cannabis legalization in Canada brought the promise of global business opportunities, but it also led to missed potential in research on the medical side. 

Even before the days of adult-use legalization in Canada, the market had seen a barrage-like cycle of ups and downs, creating uncertainty about where to find solid investment opportunities.

Keep reading... Show less

Numinus Wellness Inc. (“Numinus” or the “Company”) (TSXV: NUMI), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced that it will participate in two upcoming events hosted by Microdose:

  • Psychedelic Capital to be held virtually on Thursday, October 28, 2021 . Payton Nyquvest , Founder and CEO of Numinus, will present at 1:45 p.m. ET . To attend, please register here .
  • Wonderland: Miami to be held at the Adrienne Arsht Center for the Performing Arts in Miami, FL on November 8-9, 2021 . Mr. Nyquvest and Dr. Evan Lewis , Founder & Director of the Neurology Centre of Toronto , will give a presentation called Psychedelic Neurology in the Treatment of Trauma on Monday, November 8 at 4:40 p.m. ET . In addition, Sharan Sidhu , Science Officer & General Manager of Numinus, will participate in the Patent Wars panel on Tuesday, November 9 at 4:30 p.m. ET . To attend, please register here .

For more information about the events or to schedule a one-on-one meeting with Numinus‘ management, please contact KCSA Strategic Communications at .

Keep reading... Show less

Florida’s leading cannabis company to open three new Miami dispensaries

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), the largest multi-state operator (MSO) in the United States today announced the reopening of three medical marijuana dispensaries in Miami, Florida . The locations were formerly branded as Harvest House of Cannabis.

Keep reading... Show less